|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 01917289.9 (espacenet) (Federated) (European Patent Register), 20010402 | | Patent/reg. no. and date | DK/EP 1272195, 20051012 | | Publication date | 20030108 | | Priority no. and date | GB 0008172, 20000405 | | EP pub. no. and date |
EP 1272195 20030108 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | THURLIMANN, Beat, Cantonal Hospital
CH-9007 St. Gallen, CH | | Representative | | | Opponent | | | IPC Class | A61K 31/565 (2006.01) , A61P 35/00 (2006.01) | | Title | Anvendelse af fulvestrant til behandling af resistent brystcancer | | Int. application no. | GB2001001500 | | Int. publication no. | WO2001074366 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
